Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants
Status:
Completed
Trial end date:
2018-01-30
Target enrollment:
Participant gender:
Summary
This study will be conducted to evaluate the relative bioavailability, pharmacokinetics,
safety, and tolerability of AVP-923 (dextromethorphan hydrobromide [DM] and quinidine sulfate
[Q] capsules) when the contents of a capsule are administered in applesauce or via a
nasogastric feeding tube, compared with administration of a capsule in healthy, fasting,
adult participants.